Award/Ranking
Seven Finnegan Partners Named to IAM Strategy 300 Global Leaders 2026 Seven Finnegan Partners Named to IAM Strategy 300 Global Leaders 2026
November 19, 2025
Intellectual Asset Management (IAM)Award/Ranking
Eleven Finnegan Attorneys Named to the 2025 IAM Strategy 300 Global Leaders List Eleven Finnegan Attorneys Named to the 2025 IAM Strategy 300 Global Leaders List
November 20, 2024
Intellectual Asset Management (IAM)Award/Ranking
Eleven Finnegan Attorneys Named to the 2024 IAM Strategy 300 List
Eleven Finnegan Attorneys Named to the 2024 IAM Strategy 300 List
August 14, 2024
Intellectual Asset Management (IAM)Commentary
3 Takeaways from Revived Obviousness Case On J&J Patent 3 Takeaways from Revived Obviousness Case On J&J Patent
April 17, 2024
Law360Award/Ranking
10 Finnegan Attorneys Named to the 2023 IAM Strategy 300 List 10 Finnegan Attorneys Named to the 2023 IAM Strategy 300 List
October 5, 2023
Intellectual Asset Management (IAM)Press Release
Finnegan Victory for BioDelivery Sciences International in ANDA Case Affirmed Finnegan Victory for BioDelivery Sciences International in ANDA Case Affirmed
December 29, 2022
Media Mention
Del. Judge Upholds Claims in Opioid Drug IP But Axes Others Del. Judge Upholds Claims in Opioid Drug IP But Axes Others
December 20, 2021
Law360Media Mention
Actavis Infringed Constipation Drug Patent, Judge Rules Actavis Infringed Constipation Drug Patent, Judge Rules
July 22, 2019
Law360Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.